chr1-148953102-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000313431.13(PDE4DIP):āc.322A>Cā(p.Ile108Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00768 in 1,613,942 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. 7/9 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Consequence
ENST00000313431.13 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE4DIP | NM_001395426.1 | c.835-7552A>C | intron_variant | ENST00000695795.1 | NP_001382355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE4DIP | ENST00000695795.1 | c.835-7552A>C | intron_variant | NM_001395426.1 | ENSP00000512175 |
Frequencies
GnomAD3 genomes AF: 0.00489 AC: 743AN: 152076Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00473 AC: 1189AN: 251144Hom.: 0 AF XY: 0.00463 AC XY: 629AN XY: 135746
GnomAD4 exome AF: 0.00798 AC: 11660AN: 1461748Hom.: 49 Cov.: 32 AF XY: 0.00774 AC XY: 5626AN XY: 727162
GnomAD4 genome AF: 0.00488 AC: 743AN: 152194Hom.: 0 Cov.: 31 AF XY: 0.00405 AC XY: 301AN XY: 74404
ClinVar
Submissions by phenotype
not provided Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant classified as Uncertain significance and reported on 08-27-2019 by Baylor Genetics. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at